These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 30257345

  • 1. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study.
    Hidalgo-Figueroa S, Estrada-Soto S, Ramírez-Espinosa JJ, Paoli P, Lori G, León-Rivera I, Navarrete-Vázquez G.
    Biomed Pharmacother; 2018 Nov; 107():1302-1310. PubMed ID: 30257345
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G, Paoli P, León-Rivera I, Villalobos-Molina R, Medina-Franco JL, Ortiz-Andrade R, Estrada-Soto S, Camici G, Diaz-Coutiño D, Gallardo-Ortiz I, Martinez-Mayorga K, Moreno-Díaz H.
    Bioorg Med Chem; 2009 May 01; 17(9):3332-41. PubMed ID: 19362487
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives.
    Cerón-Romero L, Paoli P, Camici G, Flores-Morales V, Rios MY, Ramírez-Espinosa JJ, Hidalgo-Figueroa S, Navarrete-Vázquez G, Estrada-Soto S.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):2018-22. PubMed ID: 26961283
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
    Avupati VR, Yejella RP, Akula A, Guntuku GS, Doddi BR, Vutla VR, Anagani SR, Adimulam LS, Vyricharla AK.
    Bioorg Med Chem Lett; 2012 Oct 15; 22(20):6442-50. PubMed ID: 22981328
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
    Mahapatra MK, Kumar R, Kumar M.
    Bioorg Chem; 2017 Apr 15; 71():1-9. PubMed ID: 28126289
    [Abstract] [Full Text] [Related]

  • 6. Ursolic acid derivatives as potential antidiabetic agents: In vitro, in vivo, and in silico studies.
    Guzmán-Ávila R, Flores-Morales V, Paoli P, Camici G, Ramírez-Espinosa JJ, Cerón-Romero L, Navarrete-Vázquez G, Hidalgo-Figueroa S, Yolanda Rios M, Villalobos-Molina R, Estrada-Soto S.
    Drug Dev Res; 2018 Mar 15; 79(2):70-80. PubMed ID: 29380400
    [Abstract] [Full Text] [Related]

  • 7. Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-dione Derivatives as Novel PTP1B Inhibitors with Antidiabetic Activity.
    Li M, Li H, Min X, Sun J, Liang B, Xu L, Li J, Wang SH, Xu X.
    J Med Chem; 2024 May 23; 67(10):8406-8419. PubMed ID: 38723203
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
    Wang Z, Liu Z, Lee W, Kim SN, Yoon G, Cheon SH.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3337-40. PubMed ID: 24953600
    [Abstract] [Full Text] [Related]

  • 9. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
    Ramírez-Espinosa JJ, Rios MY, Paoli P, Flores-Morales V, Camici G, de la Rosa-Lugo V, Hidalgo-Figueroa S, Navarrete-Vázquez G, Estrada-Soto S.
    Eur J Med Chem; 2014 Nov 24; 87():316-27. PubMed ID: 25264584
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
    Hussain F, Khan Z, Jan MS, Ahmad S, Ahmad A, Rashid U, Ullah F, Ayaz M, Sadiq A.
    Bioorg Chem; 2019 Oct 24; 91():103128. PubMed ID: 31369977
    [Abstract] [Full Text] [Related]

  • 11. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
    Ghareb N, El-Sayed NM, Abdelhameed R, Yamada K, Elgawish MS.
    Bioorg Chem; 2019 May 24; 86():322-338. PubMed ID: 30743173
    [Abstract] [Full Text] [Related]

  • 12. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
    Patel AD, Barot R, Parmar I, Panchal I, Shah U, Patel M, Mishtry B.
    Curr Comput Aided Drug Des; 2018 May 24; 14(4):349-362. PubMed ID: 29701158
    [Abstract] [Full Text] [Related]

  • 13. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S, Ramírez-Espinosa JJ, Estrada-Soto S, Almanza-Pérez JC, Román-Ramos R, Alarcón-Aguilar FJ, Hernández-Rosado JV, Moreno-Díaz H, Díaz-Coutiño D, Navarrete-Vázquez G.
    Chem Biol Drug Des; 2013 Apr 24; 81(4):474-83. PubMed ID: 23289972
    [Abstract] [Full Text] [Related]

  • 14. 2,4-Thiazolidinediones as PTP 1B Inhibitors: A Mini Review (2012-2018).
    Verma SK, Yadav YS, Thareja S.
    Mini Rev Med Chem; 2019 Apr 24; 19(7):591-598. PubMed ID: 30968766
    [Abstract] [Full Text] [Related]

  • 15. Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities.
    Kumar A, Ahmad P, Maurya RA, Singh AB, Srivastava AK.
    Eur J Med Chem; 2009 Jan 24; 44(1):109-16. PubMed ID: 18436346
    [Abstract] [Full Text] [Related]

  • 16. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
    Sun J, Fu X, Liu Y, Wang Y, Huo B, Guo Y, Gao X, Li W, Hu X.
    Drug Des Devel Ther; 2015 Jan 24; 9():6327-42. PubMed ID: 26674084
    [Abstract] [Full Text] [Related]

  • 17. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
    Khan MF, Azad CS, Kumar A, Saini M, Narula AK, Jain S.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):1988-92. PubMed ID: 26965864
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors.
    Gupta S, Pandey G, Rahuja N, Srivastava AK, Saxena AK.
    Bioorg Med Chem Lett; 2010 Oct 01; 20(19):5732-4. PubMed ID: 20797859
    [Abstract] [Full Text] [Related]

  • 19. New phenylthiosemicarbazide-phenoxy-1,2,3-triazole-N-phenylacetamides as dual inhibitors against α-glucosidase and PTP-1B for the treatment of type 2 diabetes.
    Ansariashlaghi S, Fakhrioliaei A, Mohammadi-Khanaposhtani M, Noori M, Asadi M, Mojtabavi S, Faramarzi MA, Esfahani EN, Rastegar H, Larijani B, Azizian H, Mahdavi M.
    Arch Pharm (Weinheim); 2024 Jul 01; 357(7):e2300517. PubMed ID: 38593290
    [Abstract] [Full Text] [Related]

  • 20. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
    Jiang B, Luo J, Guo S, Wang L.
    Bioorg Chem; 2021 Mar 01; 108():104648. PubMed ID: 33493928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.